Shearing of surface mucin saps tumor cell strength

Trends Pharmacol Sci. 2023 Nov;44(11):755-757. doi: 10.1016/j.tips.2023.08.011. Epub 2023 Sep 5.

Abstract

Aberrant expression of transmembrane mucins promotes tumor progression and interferes with immunological and medicinal elimination of cancer cells. In a recent article, Pedram et al. directed an attenuated bacterial mucin-specific protease to HER2-positive tumor cells and observed decreased tumor growth rates and extended survival of mice bearing HER2-positive tumors.